Novabio Therapeutics
A developer of multimodal Treg cell therapies, targeting neurodegenerative, autoimmune, and metabolic diseases.
HQ location
Pudong, China
Website
Launch date
Enterprise value
$11—17m
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY20.0m | Seed | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads